• 한국임상약학회지
• /
• 제31권3호
• /
• pp.237-246
• /
• 2021

Background: Pembrolizumab, an anti-cancer drug, is known to increase the activity of the immune system, leading to side effects called immune-related adverse events (irAE), including type 1 diabetes. This study analyzed the correlation between blood glucose level and pembrolizumab administration and investigated the covariates that affect those changes in cancer treatment. Methods: The information of 133 adult cancer patients was obtained from the electronic medical record (EMR) to identify the changes in random blood glucose (RBG) levels during the pembrolizumab treatment. Subjects were classified into subgroups according to their baseline RBG level, history of diabetes, and the use of steroids, and linear regression analysis was conducted. In addition, a secondary analysis was performed within the group of subjects having a strong correlation to glycemic change, which was based on the Pearson correlation coefficient being less than -0.7 or greater than +0.7. Univariate and multivariate logistic regressions were conducted to identify the risk factors to glycemic increase. Results: The RBG level tended to descend without significant differences in total patients during the administration period of pembrolizumab. Despite the insignificance, the logistic regression analysis presents that the odds ratios of baseline RBG less than 130 mg/dL, prophylactic steroid use, and higher dose of pembrolizumab per cycle (mg/kg/cycle) were greater than 1. Conclusions: Prophylactic administration of steroids and a higher dose of pembrolizumab per cycle may increase the blood glucose level as irAE in cancer patients with a strong tendency to glycemic change.

• 사상체질의학회지
• /
• 제30권4호
• /
• pp.33-52
• /
• 2018

Objectives The purpose of this study was to analyze the clinical characteristics of patients with hyperhidrosis who visited a Korean medicine hospital, and provide information on treated hyperhidrosis, based on Sasang Constitutional medicine. Methods A retrospective review was made of the electronic medical record (EMR) charts for 157 Korean patients with hyperhidrosis (90 male, 67 female), who first visited hospital from January 1, 2013 to December 31, 2017. The following information was collected: sex, age, height, weight, body mass index (BMI) and clinical data (diagnosis, area of onset, duration of illness, aggravating factors, medication, healing process, et al). Results There were many patients with hyperhidrosis, in the other of So-Yang type (57.3%), Tae-Eum type (35.0%) and So-Eum type (7.6%). The proportion of male was higher than female. The most common area of hyperhidrosis was hands and feet (44.0%), followed by generalized whole body (27.4%) and head and face (25.5%). The cure rate of hyperhidrosis was 32.2%, and effectiveness rate of that was 72.7%. In individual patients, the better the usual health condition expressed by original symptoms, the higher the possibility of treatment success, with shortened duration of treatment and reduced total drug dose. The most frequent treatment modality in patients was that consistently improved, and this duration of treatment was statistically significantly shorter than that experienced worsening of excessive sweating during treatment period (p<0.001). Conclusions This study provides some original information on the Korean patients with hyperhidrosis, and suggests the suitability of Sasang Constitutional medicine as treatment methods for hyperhidrosis.

• 대한방사선기술학회지:방사선기술과학
• /
• 제31권1호
• /
• pp.1-10
• /
• 2008

최근의 IT, BT와 NT의 발달로 U-헬스케어가 도입되고, 원격진료 및 전자의무기록(EMR), 의료영상저장전송시스템(PACS) 등의 보편화는 의료정보시스템을 때와 장소를 가리지 않는 유비쿼터스 의료 환경으로 진화시키고 있다. 이에 병원은 의료정보시스템의 활성화 및 보편화를 적극적으로 장려하며, 국가 차원의 디지털 의료정보의 통합 및 의료기관간 네트워크화가 구축하여 유 무선 의료 통신망이 개방되고, 환자의 진료 데이터 및 영상 공유가 실시되고 있다. 그리고 의료 산업 분야에서는 의료장비, 의료정보시스템, 의료 애플리케이션 등 관련 기술이 복잡화, 고도화되는 추세를 나타내고 있다. 이전의 의료정보 표준은 HL7, DICOM, IHE, ASTM 등의 많은 관련 기구가 독자적으로 기술 표준을 제정하는 상황으로 대부분의 기술들이 국가 간, 동일 국가의 지역 내, 업체 간 긴밀한 상호 관계없이 독립적으로 개발 및 구현이 되고 있어, 시스템의 통합 및 표준화에 어려움이 많이 있다. 이에 의료데이터의 적합성 및 상호운용성을 위하여 국제 표준화 기구는 긴밀한 협조로 관련 표준을 공동 개발하는 추세이다. 본 논문에서는 최근의 의료정보기술 표준화 동향을 살펴보고, 향후의 의료정보시스템의 전망을 예측하여 실제 국내에서 의료정보 및 애플리케이션 개발에 필요한 의료정보 표준을 제시하고자 한다. 특히 최근 각 선진국들의 의료정보 표준화를 기술 선점의 기회로 국가적 차원에서 지원이 증대함에 따라 의료산업 및 의료정보기술의 표준 연구가 절실하다고 생각된다. 결과적으로 환자 중심의 의료정보 환경에서의 국내 의료기관의 정보화 촉진 및 선진화를 도모하기 위하여 의료정보 표준의 국내 적용의 개발이 선행되어야 하며, 병원 및 의료 산업에서 의료정보 표준 정착과 공유 활용의 기반을 마련하는 의료정보시스템을 구축하여야 할 것으로 생각된다.

• 한국방사선학회논문지
• /
• 제6권2호
• /
• pp.143-149
• /
• 2012

오늘날 의료영상매체의 획기적인 발전으로 각 병원에서 최신 의료장비를 도입함으로써 첨단화, 디지털화로 급변하는 추세이다. 이러한 움직임에 발맞추어 방사선 종양학과에서도 CR system을 도입하여 film system의 단점을 보완하고 병원에서 사용하고 있는 Picture Archiving and Communication System(PACS)과 Electronic Medical Record (EMR) , 그리고 Radiation therapy Treatment Planning system(RTP)의 network를 원활히 하여 업무효율 증대 및 환자에 대한 의료의 질 개선과 서비스 향상을 이루고자 하고 있는데, 방사선 종양학과의 Computed Radiography system(CR system)을 이용하여 PACS에 통합한 사례를 소개하고 그 유용성을 평가하고자 한다. 의료용 선형가속기인 MEVATRON-MX를 이용하여 현재 시행하고 있는 정도관리 중 Gantry, Collimator Star Shot, Light vs. Radiation Field Accuracy, HDR QA(Dwell position accuracy)를 시행하여 PACS 상에 구현하였고 모니터 상에서 디지털 영상을 통한 QA가 가능한지 확인하였다. 또한, 현재 S병원에서 사용 중인 Operation Control System(OCS)과 연동하여 치료에 필요한 코드를 각각의 치료에 부과하여 네트워크로 연결, CR상에 입력한 order가 나타나도록 하였으며, Planning System인 Pinacle과 PACS상의 지원 data 오류를 해결하여 PACS 상에서도 Planning 영상을 볼 수 있도록 하였다. CR system을 이용하여 L-gram, simulation image, planning image를 병원 내 어느 곳에서나 영상을 조회하고 볼 수 있게 PACS에 통합 구축되어있다. Filmless 환경에서 Dosimetry용 IP를 이용하여 Light/Radition field size 일치, gantry rotation axis의 정확성, collimator rotation axis의 정확성, brachy therapy의 Dwell position check등 QA의 시행이 가능하였다. CR system을 이용하여 방사선 종양학과에서 얻어지는 영상을 PACS에 통합함으로써 작업시간 단축과 그에 따른 불필요한 인력소모의 감소 등으로 인하여 업무효율이 증대되었지만 향후 환자정보에 대한 보안을 필요로 한다.

• 사상체질의학회지
• /
• 제30권3호
• /
• pp.62-73
• /
• 2018

Objectives The aim of this study was to make an analysis of clinical characteristics and status of Sasang constitutional medicine of patients with Parkinson's Disease who visited a Korean medicine hospital. Methods We studied 129 patients with Parkinson's Disease who visited a Korean medicine hospital from September 1, 2012 to June 30, 2018. We retrospectively collected medical history and characteristics of subjects using data of EMR (electronic medical record). Results The proportion of female was higher than male. The average age was 60s. The patients visited a hospital more than one year after the occurrence of symptoms. And they were mostly under western medicine treatment. Among the 129 patients, 56 persons(43.4%) were Taeeumin, 45 persons(34.9%) Soyangin and 28 persons Soeumin(21.7%). In the distribution of prescription according Sasang Constitutional Medicine symptomatology, there was no significant difference in the proportion of exterior cold disease(48.9%) and interior heat disease(51.1%) in Soyangin. Meanwhile the proportion of heat disease's prescription was higher than cold disease in Taeeumin(73.2%) and Soeumin(84.1%). The majority of disease were Dry-febrile symptom(73.2%) of heat disease in Taeeumin, Yang depletion-syndrome(64.3%) of heat disease in Soeumin, and Gyolhyung-symptom(33.3%) of exterior cold disease and Wasting thirst-syndrome(22.2%) of interior heat disease in Soyangin, Conclusions By Developing of guideline for treatment of Parkinson's Disease through analyzing on clinical characteristics and distribution of Sasang Constitutional Medicine symptomatology could contribute to the improvement of the cure rate and accuracy of constitution pattern.

• 한국임상약학회지
• /
• 제22권3호
• /
• pp.211-219
• /
• 2012

Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the treatment of extensive diseases related to various symptoms; inflammation, pain and fever. NSAIDs work by blocking prostaglandin synthesis, but adverse drug events (ADEs) have been increasing dramatically such as gastrointestinal bleeding, perforation and stenosis, a kind of serious ADEs. Therefore, NSAID-related ulcer complication guidelines have been announced containing various risk factors and symptoms. Thus, this study aims to evaluate of NSAID usage and appropriateness for prevention of NSAID-related ulcer complication based on American journal of gastroenterology (AJG) guideline 2009. Further, the study suggests Korean guideline for prevention of NSAID-related ulcer compared to AJG guideline. For this study, data was collected through electronic medical record (EMR) at Seoul national university of Bundang hospital. The primary end point was a composite of NSAID-related ulcer risk factor, types of NSAIDs, co-prescribed NSAID ulcer prevention drugs and NSAID-related ulcer after taking NSAID. The risk factors include over 65 years, high dose NSAID, previous ulcer history and taking drugs (e.g. aspirin, anticoagulant and steroid) causing ulcer. If a patient has 3 or 4 factors, that patient was classified high risk group. And if 1 or 2 factors that patient was classified moderate risk group. The patient who has no risk factor was in low risk group. I studied 8,120 patients who received NSAID from 1 January 2009 to 31 December 2009. High risk group was 16(0.2%), moderate risk group was 4,364(53.7%), and low risk group was 3,740(46.1%). The results show that high risk group should be prescribed COX-2 inhibitors with ulcer prevention drugs, and moderate or low risk group need traditional NSAIDs with ulcer prevention drugs. This may be different with 2009 AJG guideline because AJG guideline suggested taking COX-2 inhibitor alone in moderate group or taking traditional NSAID alone in low risk group could get higher ulcer complication. The results indicated that choosing preventive drug is important in case that how many risk factors the patients have. The proper drugs would be helpful for safe and effective NSAID usage in each patient group.

• 한국임상약학회지
• /
• 제28권3호
• /
• pp.167-173
• /
• 2018

Background: In July 2016, the Infectious diseases society of america and the american thoracic society (IDSA & ATS) published a guideline recommending piperacillin/tazobactam (Pip/Tazo) 18 g/day as the anti-pseudomonal dose for the treatment of pathogenic pneumonia. After the guideline was published, the Pip/Tazo dose used for the treatment of pathogenic pneumonia was changed from 13.5 g/day to 18 g/day in a superior general hospital intensive care unit (ICU). In this study, we analyzed the effectiveness and safety of the new dose. Methods: Adult patients aged ${\geq}19years$ who were diagnosed with pneumonia in ICU and who received Pip/Tazo for 7 days or more from September 1, 2015 to May 31, 2017 were included in the study. The electronic medical record (EMR) was retrospectively analyzed. Results: At baseline, there was a significant difference between 44 patients treated with 13.5 g/day and 31 patients treated with 18 g/day of Pip/Tazo. The 18 g/day-treatment group comprised more elderly patients than the 13.5 g/day-treatment group (p=0.028). The results of the treatment-effects analysis showed no significant difference between the two groups. In case of safety data, there were significant differences in two parameters related to blood count, namely hemoglobin (p=0.016) and platelet count (p=0.011). Conclusion: Based on the significant difference in baseline age, there is a possibility that high-dose Pip/Tazo showed improved therapeutic effect. However, when high-dose Pip/Tazo was used, the blood cell count was found to drop from the reference value more frequently. Therefore, blood cell count should be monitored carefully when high-dose Pip/Tazo is administered.

• 핵의학기술
• /
• 제25권1호
• /
• pp.21-28
• /
• 2021

갈색지방세포(Brown fat 또는 Brown Adipose Tissue, BAT)는 포도당 대사(glucose metabolism)와 비오한성 열생성(non-shivering thermogenesis)을 통하여 열을 발산하여 추위로부터 생명체를 보호한다. BAT의 활성화는 연령, 성별, 체질량지수(BMI) 등의 환자 내적 요인과 기온, 환경 등의 환자외적 요인에 의해 확률적으로 발생한다. 본 연구에서는 후향적, 의무기록 관찰 연구를 진행하여 여러 인자들을 추출하고 통계 분석을 실시하여 BAT 활성화와 여러 인자 간에 관련성을 확인하고자 한다. 2018년 1월부터 2019년 12월까지 2년간 국립암센터에서 PET/CT 검사를 시행한 환자의 의무기록을 수집하여 총 9155명의 환자를 추출하고 중복 검사를 포함한 13442건의 환자데이터를 대상으로 하였다. 환자데이터의 의무기록에서는 BAT 발생여부, 성별, 검사당시 나이, 영상촬영날짜, 검사장소, 주사시간, 키, 체중, 혈당, 진단명이 나오도록 조건을 설정하였다. BAT 활성화가 PET/CT 촬영 시 환경(기온, 검사장소)과 환자의 상태(혈당, BMI, 암의 종류, 성별, 나이)에 따라 영향을 받는지 확인하기 위하여 단변량 로지스틱 회귀분석을 실행한 후, P<0.1인 변수를 선택하여 BAT 활성화에 영향을 주는 다변량 회귀분석 모형을 최종적으로 분석하였다. BAT 활성화는 전체 13442건 중 93건(0.7%)이 발생되었다. 단변수 로지스틱 회귀분석 결과에서 유의한 결과는, 50세 이상인 환자보다 50세 미만인 환자에게서(P<0.001), 여성이 남성에 비해서(P<0.001), 외부기온 14.5도 미만에서(P<0.001), 정상 BMI보다 낮은 BMI에서(P<0.001), 혈당이 100mg/dl 미만에서(P<0.001), 오후 12시 30분 이전에 주사를 맞은 환자에게서(P<0.001) BAT 활성화가 증가하였다. 반면, 정상보다 높은 BMI에서(P<0.001), 폐암진단을 받은 환자에게서(P<0.05) 감소하였다. 다변수 결과에서는, 50세 미만인 환자에게서(P<0.001), 여성에게서(P<0.001), 외부기온 14.5도 미만에서(P<0.001) BAT 활성화가 유의하게 증가하였고, 정상보다 높은 BMI에서(P<0.05) 유의하게 감소하였다. 국립암센터에서 2년간 PET/CT 시행한 환자를 대상으로 BAT 활성화에 영향을 미치는 인자에 대한 후행 연구를 진행하였다. 그 결과, 외부기온 14.5도 미만의 날씨에 PET/CT 검사를 시행했던 50대 미만의 정상 체중 여성에게서 BAT가 유의하게 활성화가 되었음을 확인할 수 있었다. 이 결과를 토대로 해당 인자에 적용된 환자를 사전에 식별할 수 있으며, 앞으로 여러 연구를 통하여 BAT의 활성화를 줄이는 것에 도움이 될 수 있다고 사료된다.